With respect to tumor size, our results were sobering: we estimated that occult, early-stage (CIS, stage I, or stage II) serous ovarian cancers (in BRCA1 women) have a median diameter of less than 0.3 cm and spend, on average, more than 90% of the duration of the window of opportunity for early detection at a diameter of less than 0.9 cm (Figure S9). This evidence concerns the gene BRCA1 and ovarian serous adenocarcinoma.